Workflow
Rimag Group(02522)
icon
Search documents
一脉阳光拟折让约12.53%配售3500万股配售股份 净筹约5.62亿港元
Zhi Tong Cai Jing· 2025-08-21 23:47
Core Viewpoint - The company, Yipai Sunshine (02522), has entered into a placement agreement to issue 35 million shares at a price of HKD 16.76 per share, representing a discount of approximately 12.53% from the last trading price of HKD 19.16 on August 21, 2025 [1] Summary by Categories Placement Details - The placement involves a total of 35 million shares, which accounts for about 11.93% of the company's issued H-shares as of the announcement date [1] - The expected net proceeds from the placement, after deducting commissions and related costs, are approximately HKD 562 million [1] Use of Proceeds - Approximately 40% of the net proceeds will be allocated to the development of data and artificial intelligence, focusing on medical imaging data services and establishing strategic partnerships with leading companies and hospitals [1] - About 30% of the net proceeds will be used for expanding the company's medical imaging center business through investments or acquisitions, targeting both domestic and overseas markets [1] - Approximately 20% of the net proceeds will be invested in establishing an incubation fund for quality healthcare enterprises, enhancing the company's industry influence [1] - The remaining 10% of the net proceeds will be allocated for general working capital [1]
一脉阳光(02522)拟折让约12.53%配售3500万股配售股份 净筹约5.62亿港元
智通财经网· 2025-08-21 23:44
Core Viewpoint - The company, Yipai Sunshine (02522), has announced a placement agreement to issue 35 million shares at a price of HKD 16.76 per share, representing approximately 11.93% of the enlarged issued H shares as of the announcement date [1] Summary by Categories Placement Details - The placement price of HKD 16.76 per share reflects a discount of about 12.53% compared to the closing price of HKD 19.16 on August 21, 2025 [1] - The expected net proceeds from the placement, after deducting commissions and related costs, will be approximately HKD 562 million [1] Use of Proceeds - Approximately 40% of the net proceeds will be allocated to the development of data and artificial intelligence, focusing on medical imaging data mining, annotation, and cleaning services, as well as the development of AI application platforms [1] - About 30% of the net proceeds will be used for the expansion of the company's medical imaging center business and enabling solutions through self-investment or acquisitions, targeting both domestic and overseas markets such as Hong Kong and Singapore [1] - Approximately 20% of the net proceeds will be invested in or used to establish an industrial incubation fund to invest in quality healthcare companies and third parties that align with the group's business resources [1] - The remaining 10% of the net proceeds will be allocated for general working capital [1]
一脉阳光(02522.HK)拟配股净筹5.62亿港元 加码医学影像AI与市场扩张
Ge Long Hui· 2025-08-21 23:03
Core Viewpoint - The company, Yipai Yangguang (02522.HK), has announced a placement agreement to issue 35 million shares at a price of HKD 16.76 per share, which represents approximately 13.55% of the existing H-shares and 9.58% of the total issued shares as of the announcement date [1][2]. Group 1 - The placement is expected to raise approximately HKD 586.6 million in total proceeds, with a net amount of about HKD 562.1 million after expenses [2]. - The net proceeds from the placement will be allocated as follows: approximately 40% for the development of data and artificial intelligence in medical imaging, 30% for expanding the medical imaging center business through investments or acquisitions, 20% for establishing an incubation fund for quality healthcare enterprises, and 10% for general working capital [2]. Group 2 - The company aims to deepen its capabilities in data services related to medical imaging by collaborating with leading enterprises in AI and healthcare, as well as major hospitals in China [2]. - The strategic focus includes establishing a data space and creating a convertible imaging center, while also building an investment portfolio in high-quality enterprises within the medical field [2].
一脉阳光(02522) - 根据一般授权配售新H股
2025-08-21 22:47
本公告或其任何副本概不得直接或間接於美國境內或有關刊發或派發屬違法的任何其他司法權 區刊發或派發。本公告僅作參考用途,並不構成收購、購買或認購本公司任何證券之邀請或要 約。 本公告並不構成或組成於美國境內或有關發售屬違法的任何其他司法權區出售或購買或認購證 券的任何要約或招攬的一部分。本公告所述本公司股份並無亦不會根據1933年美國證券法(經 修訂)(「美國證券法」)登記,且不得於美國境內提呈發售或出售,惟根據美國證券法登記規定 進行登記者或獲豁免遵守該等登記規定者除外。本公司無意根據美國證券法登記本公告內所指 之任何證券,或在美國境內進行證券公開發售。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:2522) 根據一般授權配售新H股 整體協調人及配售代理 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 於2025年8月22日(交易時段前),本公司與配 ...
智通港股通占比异动统计|8月21日
智通财经网· 2025-08-21 00:43
在最近有统计数据的5个交易日内,恆生中国企业(02828)、一脉阳光(02522)、南方恆生科技 (03033)港股通持股占比增加值最大,分别增加8.52%、4.91%、4.08%;东阳光药(06887)、锦欣生 殖(01951)、第四范式(06682)港股通持股占比减少值最大,分别减少-5.00%、-3.95%、-3.71%。 具体数据如下(交易所数据根据T+2日结算): 1、港股通最新日占比增持榜(前20名) 智通财经APP获悉,根据2025年8月20日披露数据,京城机电股份(00187)、一脉阳光(02522)、安 井食品(02648)港股通持股占比增加值最大,分别增加3.04%、3.04%、1.93%;盈富基金(02800)、 锦欣生殖(01951)、山东墨龙(00568)港股通持股占比减少值最大,分别减 少-3.86%、-1.81%、-1.25%。 | 公司名称 | 占比值变动 | 最新持股比例 | | --- | --- | --- | | 京城机电股份(00187) | +3.04% | 45.45% | | 一脉阳光(02522) | +3.04% | 39.10% | | 安井食品(0264 ...
智通港股通活跃成交|8月19日
智通财经网· 2025-08-19 11:03
Core Insights - On August 19, 2025, Oriental Selection (01797), Tracker Fund of Hong Kong (02800), and Tencent Holdings (00700) were the top three stocks by trading volume in the Southbound Stock Connect, with trading amounts of 7.043 billion, 5.106 billion, and 3.221 billion respectively [1] - In the Shenzhen-Hong Kong Stock Connect, Oriental Selection (01797), Hang Seng China Enterprises Index ETF (02828), and Tracker Fund of Hong Kong (02800) were the top three stocks, with trading amounts of 3.294 billion, 2.215 billion, and 2.021 billion respectively [1] Southbound Stock Connect - Top Active Companies - Oriental Selection (01797) had a trading amount of 7.043 billion with a net buy of -48.8231 million [2] - Tracker Fund of Hong Kong (02800) recorded a trading amount of 5.106 billion with a net buy of 5.089 billion [2] - Tencent Holdings (00700) had a trading amount of 3.221 billion with a net buy of 979 million [2] - Alibaba Group (09988) had a trading amount of 2.547 billion with a net buy of -7.2321 million [2] - SMIC (00981) recorded a trading amount of 2.084 billion with a net buy of 160.3 million [2] Shenzhen-Hong Kong Stock Connect - Top Active Companies - Oriental Selection (01797) had a trading amount of 3.294 billion with a net buy of -464 million [2] - Hang Seng China Enterprises Index ETF (02828) recorded a trading amount of 2.215 billion with a net buy of 2.215 billion [2] - Tracker Fund of Hong Kong (02800) had a trading amount of 2.021 billion with a net buy of 1.982 billion [2] - Tencent Holdings (00700) recorded a trading amount of 2.018 billion with a net buy of 46.322 million [2] - Alibaba Group (09988) had a trading amount of 1.984 billion with a net buy of 268 million [2]
港股市场新消费概念股普跌,截至午盘,布鲁可跌超8%,老铺黄金跌超3%,锅圈、泡泡玛特跌超2%
Ge Long Hui· 2025-08-19 04:30
Group 1 - The Hong Kong stock market's new consumption concept stocks experienced a widespread decline, with notable drops in several companies [1] - Blucco (00325) saw a significant decrease of 8.27%, closing at 112.000 [2] - Other companies such as Laopu Gold (06181) and Pop Mart (09992) also faced declines of 3.44% and 2.32% respectively [2] Group 2 - Additional companies in the new consumption sector, including Qi (02517) and Weilon Delicious (09982), reported declines of 2.50% and 2.12% respectively [2] - Xpeng Motors (09868) and Li Auto (02015) experienced minor declines of 1.66% and 1.51% [2] - Other companies like Juzhi Biotechnology (02367) and Mijue Group (02097) also showed slight decreases, indicating a broader trend in the market [2]
智通港股通占比异动统计|8月19日
智通财经网· 2025-08-19 00:40
Core Insights - The report highlights significant changes in the Hong Kong Stock Connect holdings, with notable increases and decreases in ownership percentages for various companies [1][2]. Group 1: Increased Holdings - 京城机电股份 (00187) saw the largest increase in holdings, up by 2.42%, bringing its total to 49.96% [2]. - 一脉阳光 (02522) experienced a 1.76% increase, resulting in a holding of 35.32% [2]. - 微盟集团 (02013) had a 1.13% increase, with a current holding of 33.76% [2]. - In the last five trading days, 长飞光纤光缆 (06869) had the highest increase at 4.25%, now holding 55.68% [4]. - FORTIOR TECHNOLOGY (SHENZHEN) CO., LTD. (01304) increased by 3.12%, reaching 6.02% [4]. Group 2: Decreased Holdings - 荣昌生物 (09995) experienced the largest decrease in holdings, down by 3.69%, now at 51.39% [2]. - 东阳光药 (06887) saw a reduction of 0.92%, with a holding of 47.90% [2]. - 山东墨龙 (00568) decreased by 0.88%, now at 56.49% [2]. - Over the last five trading days, 东阳光药 (06887) had the most significant drop at 5.14%, bringing its holding to 47.90% [4]. - 凯莱英 (06821) decreased by 4.46%, now holding 46.14% [4].
一脉阳光发布中期业绩 股东应占溢利1644.3万元 同比增加328.65%
Zhi Tong Cai Jing· 2025-08-18 12:28
Core Viewpoint - The company reported a significant increase in mid-term performance for the six months ending June 30, 2025, with revenue reaching 467 million RMB, a year-on-year increase of 12.89% [1] Financial Performance - Revenue for the reporting period was 467 million RMB, with a gross profit of 137 million RMB [1] - Shareholder profit attributable to the company was 16.44 million RMB, reflecting a substantial year-on-year increase of 328.65% [1] - Basic earnings per share were reported at 0.046 RMB [1] Business Strategy and Market Position - The increase in revenue was primarily driven by a rise in customer numbers, despite macroeconomic slowdowns and adjustments in the reform process [1] - The company maintained stable revenue growth in its core imaging center services, even amidst industry cyclical adjustments [1] - The company is actively adjusting its business pace and expanding its medical imaging center network through investments, mergers, and the incubation of industrial funds [1] Future Outlook - New imaging center projects are expected to gradually commence operations in the second half of 2025 [1] - The ongoing release of national medical infrastructure policies is anticipated to boost business revenue significantly, with a recovery in demand for medical equipment expected by the end of 2024 [1] - The company is developing more flexible and diverse products, which have led to a notable increase in customer numbers, injecting new vitality into revenue growth [1]
一脉阳光(02522.HK)发布中期业绩 股东应占溢利1644.3万元 同比增加328.65%
Jin Rong Jie· 2025-08-18 11:51
一脉阳光(02522.HK)发布截至2025年6月30日止六个月的中期业绩,收入4.67亿元(人民币,下同),同比 增加12.89%;毛利1.37亿元;股东应占溢利1644.3万元,同比增加328.65%;每股基本盈利0.046元。 本文源自:金融界AI电报 ...